Home / Healthcare It / Asthma Drugs Market – Saudi Arabia Insights

Asthma Drugs Market – Saudi Arabia Insights

  • Id : RNR-831606
  • Category : Healthcare It
  • Publish Date : 2020
  • Pages : 100
  • Format : PDF
License Type

Description
Please find bellow molecules name table along with our main requirements. 
 
•	Historical and forecasted market size (volume and value) for the 16 molecules .
•	Breakdown of the asthma products market between private and public sector sales.
 
 
Molecule Name	Type
BUDESONIDE + FORMOTEROL 160 MCG/4.5 MCG TURBOHALER	DPI
FLUTICAZONE 50 MCG + SALMETEROL XINAFOATE 25 MCG EVOHALER	MDI
FLUTICAZONE 125 MCG + SALMETEROL XINAFOATE 25 MCG EVOHALER	MDI
FLUTICASONE 250 MCG+ SALMETEROL XINAFOATE 25 MCG /PUFF EVOHALER	MDI
FLUTICASONE 250 MCG + SALMETEROL XINAFOATE 50 MCG DISKUS	DPI
FLUTICASONE 500MCG + SALMETROL 50MCG DISKUS INHALER	DPI
FLUTICASONE FUROATE 27.5MCG NASAL SPRAY	MDI
SALBUTAMOL 100 MCG INHALER 200 DOSES 100 MCG/PUFF	MDI
FLUTICASONE PROPIONATE 250MCG+ FORMOTEROL FUMARATE 10MCG	MDI
FLUTICASONE PROPIONATE 125 MCG PUFF INHALER	MDI/DPI
FLUTICASONE PROPIONATE 50 MCG INHALER	MDI
FLUTICASONE PROPIONATE 250 MCG PUFF INHALER	MDI/DPI
BUDESONIDE 200 MCG/PUFF TURBOHALER (200 DOSES OR PUFFS)	DPI
BUDESONIDE 500 MCG/ML 2 ML NEBULIZER	Respules (Inhalation suspension)
BUDESONIDE 250 MCG/ML 2ML NEBULIZER	Respules (Inhalation suspension)
SALBUTAMOL 2.5MG/2.5ML NEBULE	Respules (Inhalation suspension)